StonvexLoading…
StonvexStonvexStonvexCore line items from SCL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.33B | $2.18B | $2.33B | $2.77B |
Operating Income | $78.55M | $70.48M | $58.61M | $207.34M |
Net Income | $46.90M | $50.37M | $40.20M | $147.15M |
EPS (Diluted) | $2.05 | $2.20 | $1.75 | $6.38 |
Total Assets | $2.36B | $2.30B | $2.36B | $2.43B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $132.69M | $99.67M | $129.82M | $173.75M |
Free Cash Flow OCF − CapEx | $25.37M | $39.28M | $-85.46M | $-140.79M |
Shares Outstanding | 22.89M | 22.93M | 22.95M | 23.06M |